Abstract
Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
Keywords: Polypoidal choroidal vasculopathy, choroidal neovascularization, age-related macular degeneration, photodynamic therapy, antiVEGF, triamcinolone, combination therapy, retinal pigment epithelium (RPE), neurosensory retina, serosanguinous retinal pigment epithelial (RPE), macula, extrafovea, subfovea, juxtafovea, Optical Coherence Tomography, fundus, Fluorescein Angiography, Indocyanine Green Angiography, hemorrhage, vascular dilations, transpupillary thermotherapy (TTT), Laser Photocoagulation, polypoidal lesion, photothrombosis, Intravitreal Anti-VEGF Therapy, Intravitreal Triamcinolone Acetonide
Current Drug Targets
Title: Polypoidal Choroidal Vasculopathy: Recent Advances in Therapy
Volume: 12 Issue: 2
Author(s): G. de Crecchio, R. V.P. Chan, G. Manzi and M. R. Romano
Affiliation:
Keywords: Polypoidal choroidal vasculopathy, choroidal neovascularization, age-related macular degeneration, photodynamic therapy, antiVEGF, triamcinolone, combination therapy, retinal pigment epithelium (RPE), neurosensory retina, serosanguinous retinal pigment epithelial (RPE), macula, extrafovea, subfovea, juxtafovea, Optical Coherence Tomography, fundus, Fluorescein Angiography, Indocyanine Green Angiography, hemorrhage, vascular dilations, transpupillary thermotherapy (TTT), Laser Photocoagulation, polypoidal lesion, photothrombosis, Intravitreal Anti-VEGF Therapy, Intravitreal Triamcinolone Acetonide
Abstract: Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
Export Options
About this article
Cite this article as:
de Crecchio G., V.P. Chan R., Manzi G. and R. Romano M., Polypoidal Choroidal Vasculopathy: Recent Advances in Therapy, Current Drug Targets 2011; 12 (2) . https://dx.doi.org/10.2174/138945011794182782
DOI https://dx.doi.org/10.2174/138945011794182782 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
DNA Damage and Epigenetic Changes in Kidney Diseases - Focused on Transcription Factors in Podocytes
Current Hypertension Reviews Editorial [Hot Topic: Current Hypertension Reviews: Hot Topics Hypertension and Diabetes: An Emphasis on the RAS (Guest Editors: Karin A.M. Jandeleit-Dahm and Terri J. Allen)]
Current Hypertension Reviews The Potential Role of Antioxidants in Metabolic Syndrome
Current Pharmaceutical Design An Efficacy and Safety Study of Remogliflozin in Obese Indian Type 2 Diabetes Mellitus Patients Who Were Inadequately Controlled on Insulin Glargine Plus other Oral Hypoglycemic Agents
Current Diabetes Reviews The Role of Endothelin-1 in Obstructive Sleep Apnea Syndrome and Pulmonary Arterial Hypertension: Pathogenesis and Endothelin-1 Antagonists
Current Medicinal Chemistry Angiotensin-(1-7), Angiotensin-Converting Enzyme 2 and Mas Receptor in Rat Polycystic Ovaries
Protein & Peptide Letters Effect of the Interaction Between Hypertension and Cerebral White Matter Changes on the Progression of Alzheimer Disease
Current Alzheimer Research Designing Peptidomimetics
Current Topics in Medicinal Chemistry The Role of Endothelial Progenitor Cells and Statins in Endothelial Function: A Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Lipid Lowering Therapy in the Elderly: Is there a Benefit?
Current Pharmaceutical Design Cardiovascular Effects of Coumarins Besides their Antioxidant Activity
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Graphical Abstracts
Letters in Drug Design & Discovery GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cardiac Amyloid - A Hidden Contributor to Cardiac Dysfunction Following Cardiac Surgery: Case Report and Literature Review
Current Cardiology Reviews Inhibition of Candida rugosa Lipase by Secondary Metabolites Extracts of Three Algerian Plants and their Antioxydant Activities
Current Enzyme Inhibition Antihypertensive Therapy: Role of Aldosterone Antagonists
Current Pharmaceutical Design Genesis of Dihydropyrimidinone Calcium Channel Blockers: Recent Progress in Structure-Activity Relationships and Other Effects
Mini-Reviews in Medicinal Chemistry Insights Into Effects of Ellagic Acid on the Nervous System: A Mini Review
Current Pharmaceutical Design Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants
Current Pharmaceutical Design